Last reviewed · How we verify
Chinese herbal formula (CCH1)
A Chinese herbal formula that modulates multiple biological pathways to produce therapeutic effects, though the precise mechanism remains incompletely characterized.
At a glance
| Generic name | Chinese herbal formula (CCH1) |
|---|---|
| Also known as | TCM |
| Sponsor | National Taiwan University Hospital |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Chinese herbal formulas typically contain multiple plant-derived compounds that act synergistically on various molecular targets and physiological systems. CCH1 is in phase 3 development at National Taiwan University Hospital, but without published mechanism data, the specific molecular targets and pathways involved are not publicly detailed. The therapeutic effects likely result from combined anti-inflammatory, antioxidant, or immunomodulatory activities of constituent herbs.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chinese herbal formula (CCH1) CI brief — competitive landscape report
- Chinese herbal formula (CCH1) updates RSS · CI watch RSS
- National Taiwan University Hospital portfolio CI